review Open AccessTop 1% cited
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
Leukemia · 2016 · Vol. 30(8) · pp. 1648–1671
Juan Luis Steegmann✉(Hospital Universitario de La Princesa)Michele BaccaraniMassimo Breccia(Sapienza University of Rome)Luis Felipe Casado(Hospital Virgen de la Salud)Valentín García‐Gutiérrez(Hospital Universitario Ramón y Cajal)Andreas Hochhaus(Jena University Hospital)D.-W. Kim(Catholic University of Korea)T D Kim(Charité - Universitätsmedizin Berlin)H. Jean Khoury(Emory University)P. Le Coutre(Charité - Universitätsmedizin Berlin)Jiří Mayer(University Hospital Brno)Dragana Milojković(Hammersmith Hospital)Kimmo Porkka(University of Helsinki)Delphine Réa(Hôpital Saint-Louis)Gianantonio RostiSusanne Saußele(Heidelberg University)R. Hehlmann(Medizinische Fakultät Mannheim)Richard E. Clark(University of Liverpool)
Chronic Myeloid Leukemia TreatmentsHER2/EGFR in Cancer ResearchEosinophilic Disorders and SyndromesMedicineAdverse effectChronic myeloid leukaemiaImatinibIntensive care medicineDrug holidayImatinib mesylateInternal medicineOncologyImmunology
MeSH terms
HumansProtein-Tyrosine KinasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsDrug-Related Side Effects and Adverse Reactions
Funding
- Emory University
- Imperial College London
- Catholic University of Korea
- Universitätsklinikum Jena
- Masarykova Univerzita
- Winship Cancer Institute
Citations
470
FWCI
37.54
field-weighted impact
References
274
Percentile
100%
vs. same field & year
Citations per year
Cited by
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Leukemia · 2020 · 1,470 citations
References
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Blood · 2013 · 1,979 citations
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Journal of Vascular Surgery · 1997 · 3,524 citations
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Leukemia · 2012 · 437 citations
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia
Leukemia · 2009 · 843 citations
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
Leukemia · 2016 · 845 citations
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
European Heart Journal · 2007 · 3,753 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.